JUAN SILVA: Open Payments
NPI 1790738110 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 50 payments from 20 companies in 2025. Trend: 2023 $1,452 · 2024 $1,548 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $250 |
| ABBVIE INC. | 8 | $213 |
| Boston Scientific Corporation | 1 | $156 |
| Novo Nordisk Inc | 6 | $126 |
| Lilly USA, LLC | 4 | $115 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Corcept Therapeutics | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: FREESTYLE LIBRE 3, WATCHMAN FLX, VRAYLAR, MOUNJARO, JARDIANCE, Ozempic, CAPLYTA, CREON.
Industry payments across CA — which companies pay providers there.
